Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LLY vs GSK✓SelectedUSD · GSKLLY vs GSK performance historyLatest closeAs of-2.32%11/18
Stock and ETF performance explorer

LLY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,997.9%
GSK return
+101.2%
Excess return
+1,896.7%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.3%-1.3%-1.0%-1.6%
7D-3.7%-3.1%-0.6%-2.1%
30D+11.6%-0.9%+12.5%+12.1%
3M+12.9%-4.2%+17.1%+15.4%
6M+40.3%-1.6%+41.9%+41.3%
YTD+29.4%+2.6%+26.8%+27.4%
1Y+35.1%+6.2%+28.8%+30.6%
3Y+138.4%+55.0%+83.4%+85.1%
5Y+452.6%+42.8%+409.7%+339.2%
10Y+1,997.9%+102.1%+1,895.8%+1,167.8%
All+1,997.9%+101.2%+1,896.7%+1,167.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling